369 related articles for article (PubMed ID: 17182682)
21. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
[TBL] [Abstract][Full Text] [Related]
22. Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells.
Wells SI; Aronow BJ; Wise TM; Williams SS; Couget JA; Howley PM
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7093-8. PubMed ID: 12756294
[TBL] [Abstract][Full Text] [Related]
23. Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation.
Magaldi TG; Almstead LL; Bellone S; Prevatt EG; Santin AD; DiMaio D
Virology; 2012 Jan; 422(1):114-24. PubMed ID: 22056390
[TBL] [Abstract][Full Text] [Related]
24. Transition to an irreversible state of senescence in HeLa cells arrested by repression of HPV E6 and E7 genes.
Kang HT; Lee CJ; Seo EJ; Bahn YJ; Kim HJ; Hwang ES
Mech Ageing Dev; 2004 Jan; 125(1):31-40. PubMed ID: 14706235
[TBL] [Abstract][Full Text] [Related]
25. Activation of the retinoblastoma tumor suppressor mediates cell cycle inhibition and cell death in specific cervical cancer cell lines.
Bourgo RJ; Braden WA; Wells SI; Knudsen ES
Mol Carcinog; 2009 Jan; 48(1):45-55. PubMed ID: 18506774
[TBL] [Abstract][Full Text] [Related]
26. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells.
DeFilippis RA; Goodwin EC; Wu L; DiMaio D
J Virol; 2003 Jan; 77(2):1551-63. PubMed ID: 12502868
[TBL] [Abstract][Full Text] [Related]
27. Functional analysis of E2-mediated repression of the HPV18 P105 promoter.
Thierry F; Howley PM
New Biol; 1991 Jan; 3(1):90-100. PubMed ID: 1645591
[TBL] [Abstract][Full Text] [Related]
28. Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis.
Sanchez-Perez AM; Soriano S; Clarke AR; Gaston K
J Gen Virol; 1997 Nov; 78 ( Pt 11)():3009-18. PubMed ID: 9367388
[TBL] [Abstract][Full Text] [Related]
29. Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma.
Rosty C; Sheffer M; Tsafrir D; Stransky N; Tsafrir I; Peter M; de Crémoux P; de La Rochefordière A; Salmon R; Dorval T; Thiery JP; Couturier J; Radvanyi F; Domany E; Sastre-Garau X
Oncogene; 2005 Oct; 24(47):7094-104. PubMed ID: 16007141
[TBL] [Abstract][Full Text] [Related]
30. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
31. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
32. The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins.
Stubenrauch F; Straub E; Fertey J; Iftner T
Int J Cancer; 2007 Nov; 121(10):2284-92. PubMed ID: 17583574
[TBL] [Abstract][Full Text] [Related]
33. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein.
Holland D; Hoppe-Seyler K; Schuller B; Lohrey C; Maroldt J; Dürst M; Hoppe-Seyler F
Cancer Res; 2008 Dec; 68(23):9964-72. PubMed ID: 19047178
[TBL] [Abstract][Full Text] [Related]
34. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
35. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
Wang J; Sampath A; Raychaudhuri P; Bagchi S
Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
[TBL] [Abstract][Full Text] [Related]
36. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
37. Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways.
Wells SI; Francis DA; Karpova AY; Dowhanick JJ; Benson JD; Howley PM
EMBO J; 2000 Nov; 19(21):5762-71. PubMed ID: 11060027
[TBL] [Abstract][Full Text] [Related]
38. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
39. Trans-activation of the adenovirus E2 promoter by human papillomavirus type 16 E7 is mediated by retinoblastoma-dependent and -independent pathways.
Carlotti F; Crawford L
J Gen Virol; 1993 Nov; 74 ( Pt 11)():2479-86. PubMed ID: 8245866
[TBL] [Abstract][Full Text] [Related]
40. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
